by [email protected] | Nov 27, 2023 | Gastrointestinal, immunology, Publication
ABSTRACT Background: There is limited real-world evidence on treatment patterns of patients with Crohn’s disease (CD) initiating biologics with an extensive follow-up period. This study describes persistence and dose titration among CD patients with 3 years of...
by [email protected] | Apr 28, 2022 | Gastrointestinal, immunology, Publication
Abstract Objective: This real-world study evaluated biologic treatment patterns in moderate-to-severe ulcerative colitis (UC) patients. Methods: IQVIA® PharMetrics®, IBM® MarketScan®, and Optum Clinformatics™ were pooled to identify UC patients with ≥1 claim for UC...
by [email protected] | Dec 15, 2021 | Gastrointestinal, immunology, Publication
Abstract Amanda Teeple, Janvi Sah, Rajesh Mallampati, Christopher Adams, Dexter Waters, Erik Muser Background This study examined biologic persistence, dosing, and other treatment patterns among Crohn’s disease (CD) patients that initiated adalimumab (ADA),...
by [email protected] | Nov 5, 2021 | Cardiovascular, Gastrointestinal, Publication
Authors: Steven Deitelzweig, Allison Keshishian , Amiee Kang, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Jenny Jiang, Huseyin Yuce, Gregory Y. H. Lip Abstract Background: Gastrointestinal (GI) bleeding is the most...
by [email protected] | Nov 4, 2021 | Gastrointestinal, immunology, Publication
Authors: Grace Chen, Vasantha Pedarla, Kyle D Null, Susan E Cazzetta, Qasim Rana Khan, David A Schwartz Abstract Background: Perianal fistula (PAF), a complication of Crohn’s disease (CD), is associated with substantial economic costs and poor prognosis. We...
by [email protected] | Nov 2, 2020 | Gastrointestinal, immunology, Publication
Abstract Authors: David T Rubin, Jenny Griffith, Qisu Zhang, Zsolt Hepp, Allison Keshishian Background: Although there is evidence that anti-tumor necrosis factor (TNF) utilization earlier in the inflammatory bowel disease (IBD) course and before the...
